Risk scores are statistical indicators based on prescribing patterns compared to specialty peers. They are NOT allegations of fraud, misconduct, or improper care. Many legitimate medical reasons can explain outlier prescribing.
Read our methodology →Risk Flags
Risk indicators are statistical patterns, not allegations. Learn more
18,607
Total Claims
$934K
Drug Cost
427
Beneficiaries
$2,187
Cost/Patient
Risk Score Breakdown 36/100
Score components are additive. Read full methodology
Peer Comparison vs. 110,156 Internal Medicine providers
-88%
Opioid rate vs peers
0.3% vs 2.2% avg
+55%
Cost per patient vs peers
$2,187 vs $1,411 avg
+29%
Brand preference vs peers
13.7% vs 10.6% avg
⚠️ Opioid + Benzodiazepine Co-Prescriber
This provider prescribes both opioids and benzodiazepines. The FDA has issued a Black Box Warning about the life-threatening risks of concurrent use.
Opioid Prescribing
0.3%
Opioid Rate
48
Opioid Claims
$2,423
Opioid Cost
31.3%
Long-Acting Rate
Brand vs Generic
Brand: 2,543 claims · $635K
Generic: 16,009 claims · $296K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Apixaban | 888 | $201K |
| Pimavanserin Tartrate | 15 | $36K |
| Fluticasone/Umeclidin/Vilanter | 57 | $33K |
| Linagliptin | 197 | $31K |
| Rivaroxaban | 146 | $30K |
| Fluticasone/Vilanterol | 66 | $22K |
| Tiotropium Bromide | 39 | $20K |
| Empagliflozin | 65 | $19K |
| Sitagliptin Phosphate | 65 | $18K |
| Vortioxetine Hydrobromide | 57 | $13K |
| Sacubitril/Valsartan | 36 | $12K |
| Atorvastatin Calcium | 1,075 | $10K |
| Liraglutide | 11 | $9,865 |
| Formoterol Fumarate | 13 | $9,808 |
| Potassium Chloride | 279 | $9,784 |
Prescribing Profile
Patient Profile
83
Avg Age
69%
Female
2.20
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations.Methodology · About